Skip to main content
. 2026 Jan 23;15(3):921. doi: 10.3390/jcm15030921
ACE-I Angiotensin-converting enzyme inhibitor
AGEs Advanced glycation end products
AKI Acute kidney injury
ARB Angiotensin II receptor blocker
CKD Chronic kidney disease
CRP C-reactive protein
CTGF Connective tissue growth factor
DKD Diabetic kidney disease
ECM Extracellular matrix
eGFR Estimated glomerular filtration rate
GLP-1 Ras Glucagon-like peptide-1 receptor agonists
JAK–STAT Janus kinase–signal transducer and activator of transcription pathway
KIM-1 Kidney injury molecule-1
MCP-1 Monocyte chemoattractant protein-1
MRA Mineralocorticoid receptor antagonist
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
NGAL Neutrophil gelatinase-associated lipocalin
nsMRA Non-steroidal mineralocorticoid receptor antagonist
RAAS Renin–angiotensin–aldosterone system
SGK1 Serum/glucocorticoid-regulated kinase 1
SGLT2 Sodium–glucose cotransporter 2
TGF-β Transforming growth factor beta
TNF-α Tumor necrosis factor-alpha
Wnt/β-catenin Wingless-related integration site/beta-catenin signaling pathway